PERJETA conc perf 420 mg/14 ml flac 14 ml

7680625100014 CH-62510 L01FD02 07.16.1.

Active substances:

PERJETA conc perf 420 mg/14 ml flac 14 ml
PERJETA conc perf 420 mg/14 ml flac 14 ml
PERJETA conc perf 420 mg/14 ml flac 14 ml
1 / 3
google

Details

Product number
6251001
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
pertuzumabum 420 mg, histidinum, acidum aceticum glaciale, saccharum, polysorbatum 20, aqua ad iniectabile, q.s. ad solutionem pro 14 ml.

Articles (1)

Perjeta 420 mg, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
17/12/2025
Professional SmPC
Français
17/12/2025
Professional SmPC
Italien
17/12/2025

Detailed composition

Substance Quantity Type Category
pertuzumabum
420.0 MG Substance Wirkstoff (Principe actif)
histidinum
- Substance HNIDK
acidum aceticum glaciale
- Substance HNIDK
saccharum
- Substance HNIDK
polysorbatum 20
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 2530.95
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/07/2015

Authorization holder

Roche Pharma (Schweiz) AG

4058 Basel

Authorization information

Swissmedic authorization number
62510
Drug name
Perjeta, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOPA
ATC Code
L01FD02
Authorization status
Z
Dispensation category
A
First authorization
13/08/2012
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
Mammakarzinom

Packaging details

Description (FR)
PERJETA conc perf 420 mg/14 ml flac 14 ml
Description (DE)
PERJETA Inf Konz 420 mg/14 ml Durchstf 14 ml
Market launch
13/08/2012
Narcotic (BTM)
No
Buy us a coffee Explore the data